Sleeve Lobectomy for Lung Cancer in Minimally Invasive Surgical Techniques

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University

About this trial

The goal of this multicenter observational study is to evaluate the long-term survival and perioperative outcomes of sleeve lobectomy in robotic-assisted thoracic surgery (RATS) for patients with central lung cancer when compared with video-assisted thoracic surgery (VATS) approach, both of which have been already applied to these patients in minimally invasive surgical techniques as part of their regular medical care recently. The main question it aims to answer is:

Are RATS sleeve lobectomy associated with similar or even better long-term survival and perioperative outcomes for patients with central lung cancer when compared with the VATS approach?

Eligibility criteria

Qualifiers

Age ≥ 18 years;

Clinically suspected lung cancer with a high likelihood of undergoing sleeve lobectomy;

Postoperative histopathological diagnosis confirms non-small cell lung cancer (NSCLC);

No history of malignancy within the past 5 years;

Disqualifiers

Unable to undergo surgical resection due to surgical contraindications;

Postoperative pathology does not confirm non-small cell lung cancer (NSCLC), including but not limited to benign lesions, small cell lung cancer, metastatic tumors, or an insufficient or indeterminate histopathology report;

History of malignancy within the past 5 years;

Unable to obtain follow-up data;

Trial design

Treatments tested in this trial

  • RATS Group
  • VATS group

Treatment groups

450 Participants
are divided into 1 treatment group

Sponsors and collaborators

Second Affiliated Hospital, School of Medicine, Zhejiang University

Lead sponsor

Shanghai Chest Hospital of Shanghai Jiao Tong University

Collaborator

Sir Run Run Shaw Hospital

Collaborator